Gordon Louisa G, Beesley Vanessa L, Lynch Brigid M, Mihala Gabor, McGrath Catherine, Graves Nicholas, Webb Penelope M
Griffith Health Institute, Centre for Applied Health Economics, Griffith University, University Drive, Meadowbrook QLD, 4131 Brisbane, Australia.
BMC Public Health. 2014 Sep 17;14:963. doi: 10.1186/1471-2458-14-963.
Few studies have been undertaken to understand the employment impact in patients with colorectal cancer and none in middle-aged individuals with cancer. This study described transitions in, and key factors influencing, work participation during the 12 months following a diagnosis of colorectal cancer.
We enrolled 239 adults during 2010 and 2011 who were employed at the time of their colorectal cancer diagnosis and were prospectively followed over 12 months. They were compared to an age- and gender-matched general population group of 717 adults from the Household, Income and Labour Dynamics in Australia (HILDA) Survey. Data were collected using telephone and postal surveys. Primary outcomes included work participation at 12 months, changes in hours worked and time to work re-entry. Multivariable logistic and Cox proportional hazards models were undertaken.
A significantly higher proportion of participants with colorectal cancer (27%) had stopped working at 12 months than participants from the comparison group (8%) (p < 0.001). Participants with cancer who returned to work took a median of 91 days off work (25-75 percentiles: 14-183 days). For participants with cancer, predictors of not working at 12 months included: being older, lower BMI and lower physical well-being. Factors related to delayed work re-entry included not being university-educated, working for an employer with more than 20 employees in a non-professional or managerial role, longer hospital stay, poorer perceived financial status and having or had chemotherapy.
In middle-adulthood, those working and diagnosed with colorectal cancer can expect to take around three months off work. Individuals treated with chemotherapy, without a university degree and from large employers could be targeted for specific assistance for a more timely work entry.
ACTRN12611000530921.
很少有研究致力于了解结直肠癌患者的就业影响,而针对中年癌症患者的研究则尚无。本研究描述了结直肠癌诊断后12个月内的工作参与情况变化以及影响工作参与的关键因素。
我们在2010年至2011年期间招募了239名成年人,他们在结直肠癌诊断时已就业,并接受了为期12个月的前瞻性随访。将他们与来自澳大利亚家庭、收入和劳动力动态(HILDA)调查的717名年龄和性别匹配的成年普通人群组进行比较。通过电话和邮政调查收集数据。主要结局包括12个月时的工作参与情况、工作时长变化以及重返工作岗位的时间。采用多变量逻辑回归和Cox比例风险模型进行分析。
结直肠癌患者中在12个月时停止工作的比例(27%)显著高于对照组(8%)(p < 0.001)。重返工作岗位的癌症患者平均休假91天(四分位数间距:14 - 183天)。对于癌症患者,12个月时不工作的预测因素包括:年龄较大、体重指数较低和身体健康状况较差。与工作重返延迟相关的因素包括未接受大学教育、在非专业或管理岗位为员工超过20人的雇主工作、住院时间较长、财务状况较差以及正在接受或曾经接受过化疗。
在中年时期,那些在职且被诊断为结直肠癌的人预计将休假约三个月。对于接受化疗、没有大学学位且受雇于大雇主的个体,可以针对性地提供具体帮助,以便更及时地重返工作岗位。
ACTRN12611000530921